Metabolic effects of hormonal contraception in women with and without polycystic ovary syndrome
Mosorin ME , Maria-Elina Mosorin
Author affiliations
- Oulu University Hospital ROR
Abstract not indexed.
Read at source
GLP-1 receptor agonist fertility contraception pregnancy, semaglutide tirzepatide reproductive health women, GLP-1 RA oral contraceptive absorption gastrointestinal effects, obesity PCOS GLP-1 agonist spontaneous pregnancy, semaglutide washout period before conception, GLP-1 receptor agonist PCOS insulin sensitivity fertility, Dilbaz GLP-1 contraception pregnancy outcomes, long-acting reversible contraception GLP-1 treatment, weight loss medication fertility implications women, GLP-1 RA fetal safety animal studies human data
Cite this article
Mosorin, M. E. (2024). Metabolic effects of hormonal contraception in women with and without polycystic ovary syndrome.
Mosorin ME. Metabolic effects of hormonal contraception in women with and without polycystic ovary syndrome. 2024.
Mosorin, M. E. Metabolic effects of hormonal contraception in women with and without polycystic ovary syndrome. 2024.